Lexapro Is Likely Causing These Symptoms and Should Be Urgently Reassessed
Your relative's panic attacks, increased anger, and meltdowns that began after starting escitalopram (Lexapro) are very likely medication-related adverse effects that require immediate provider evaluation and likely medication change. The FDA explicitly warns that these exact symptoms—panic attacks, new or worse irritability, agitation, and unusual behavioral changes—are serious adverse effects that warrant urgent medical attention 1.
Why This Is Almost Certainly the Medication
The FDA Medication Guide for Lexapro specifically lists the following as warning signs requiring immediate provider contact 1:
- Panic attacks (your relative now has these for the first time)
- New or worse irritability (the increased anger you describe)
- Feeling very agitated or restless (the "terrible meltdowns")
- Other unusual changes in behavior or mood
The timing is critical here: these symptoms emerged after starting the medication in someone who never had panic attacks before. This temporal relationship strongly suggests causation rather than coincidence.
The Evidence Behind This Concern
FDA Black Box Warnings Apply Here
The FDA mandates close monitoring specifically for "the emergence of agitation, irritability, or unusual changes in behavior, because these symptoms can indicate that the depression is getting worse" 2. Guidelines emphasize that monitoring should begin within 1-2 weeks of initiation, and the risk for adverse behavioral changes is greatest during the first 1-2 months of treatment 2—exactly when your relative is experiencing these problems.
Documented Paradoxical Reactions to Escitalopram
Research confirms that escitalopram can paradoxically induce panic attacks rather than treat them:
- A case report documented a patient with no anxiety history who developed frank panic attacks after citalopram (escitalopram's parent compound) dose increase, with complete resolution upon discontinuation 3
- A study found escitalopram actually prolonged fear in healthy volunteers during stress testing, contrary to its intended anxiolytic effect 4
- Recent evidence shows pretreatment anxiety predisposes patients to developing nervousness and agitation side effects on escitalopram, with significantly higher odds of these CNS side effects 5
Risk of Treatment-Emergent Mania/Hypomania
The increased anger and "meltdowns" raise concern for activation syndrome or even treatment-emergent hypomania. Multiple case reports document escitalopram inducing manic or hypomanic episodes in patients with no prior bipolar history 6, 7:
- In one case series, all three patients developed manic/hypomanic symptoms within 1 month of reaching 10-20 mg doses 6
- Symptoms resolved when escitalopram was reduced or stopped 6
- The FDA label explicitly warns about "manic episodes" that "may happen in people with bipolar disorder who take Lexapro" but also notes monitoring for "an extreme increase in activity or talking (mania)" in all patients 1
What Needs to Happen Now
Immediate Actions
Contact the prescriber urgently—do not wait for a routine appointment. The FDA guidance is clear that these symptoms require prompt evaluation 2, 1
Do not abruptly stop the medication without provider guidance, as sudden discontinuation can cause withdrawal syndrome with its own set of problems including irritability, anxiety, and confusion 1
Monitor closely for worsening, particularly any suicidal thoughts, as the risk is highest in the first 1-2 months 2
Expected Provider Response
Based on clinical guidelines, the provider should 2:
- Modify treatment since there is clearly not an adequate response (in fact, worsening) at 2+ months
- Consider whether this represents treatment-emergent activation, paradoxical anxiety worsening, or mood switching
- Likely taper and discontinue escitalopram given the clear temporal relationship and lack of prior panic history
- Consider alternative treatments: other antidepressant classes (bupropion has lower activation risk) or non-pharmacological approaches like cognitive behavioral therapy
Important Caveats
Do not let the provider dismiss this as "the depression getting worse" on its own. While guidelines note that agitation and irritability can indicate worsening depression 2, the new onset of panic attacks in someone who never had them is a red flag for medication-induced effects, not natural disease progression.
The question "why am I getting worse?" deserves a direct answer: the medication intended to help may be causing harm in this particular individual. This is a recognized phenomenon, not a treatment failure on the patient's part.
Bottom Line
The constellation of new-onset panic attacks, increased anger, and behavioral meltdowns in someone without prior panic history, occurring within the high-risk window of early SSRI treatment, strongly indicates medication-related adverse effects rather than inadequate treatment response. This requires urgent provider evaluation and likely medication change, not dose increase or "waiting it out."